Journal rankings · indicator year 2018
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2018
Hematology journal rankings 2018
78 ranked journals · Subfield in Medicine
Hematology has 78 ranked journals in 2018. The median journal has an OJR of 0.74, below the world average of 1.00, down 0.01 on 2017; Q1 starts at OJR 1.21. The top three are Blood, The Lancet Haematology, and Blood Reviews.
Ranks and citation indicators: 2018. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2015–2017, the window the 2018 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery901
- Pulmonary and Respiratory Medicine349
- Public Health, Environmental and Occupational Health289
- Cardiology and Cardiovascular Medicine280
- Oncology224
- Infectious Diseases210
- Epidemiology193
- Endocrinology, Diabetes and Metabolism162
- Neurology161
- Physiology155
- Radiology, Nuclear Medicine and Imaging146
- Psychiatry and Mental health141
- Hematology78
Show all 42 subfields
- Orthopedics and Sports Medicine115
- Pediatrics, Perinatology and Child Health101
- Ophthalmology95
- Dermatology89
- Obstetrics and Gynecology73
- Rheumatology65
- Nephrology59
- Complementary and alternative medicine54
- Pharmacology51
- Reproductive Medicine50
- Emergency Medicine42
- Geriatrics and Gerontology34
- Rehabilitation34
- Otorhinolaryngology33
- Pathology and Forensic Medicine30
- Hepatology24
- Critical Care and Intensive Care Medicine23
- Immunology and Allergy21
- Genetics20
- Anesthesiology and Pain Medicine15
- Urology15
- Gastroenterology7
- Internal Medicine4
- Transplantation3
- Family Practice2
- Health Informatics2
- Anatomy0
- Biochemistry0
- Microbiology0
78 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2017. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2015–2017, the window the 2018 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2015–2017 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2009 to 2018. | Compare |
|---|---|---|---|---|---|---|---|
1BloodElsevier BV · United States | 3.42Q1 | 9.76 0.10 up from 2017 | 2,927 | 10% | $5,500 | ||
2The Lancet HaematologyElsevier BV · Netherlands | 2.61Q1 | 6.28 0.05 down from 2017 | 315 | 39% | $7,280 | ||
3Blood ReviewsElsevier BV · United Kingdom | 2.57Q1 | 6.35 0.49 down from 2017 | 144 | 30% | $5,220 | ||
4LeukemiaSpringer Nature · United Kingdom | 2.43Q1 | 6.54 0.12 up from 2017 | 1,062 | 66% | $5,190 | ||
5Seminars in HematologyElsevier BV · United States | 1.94Q1 | 4.37 0.89 down from 2017 | 123 | 19% | $4,070 | ||
6Journal of Thrombosis and HaemostasisElsevier BV · United Kingdom | 1.91Q1 | 4.17 0.37 down from 2017 | 906 | 96% | $3,750 | ||
7HaematologicaOAFerrata Storti Foundation · Italy | 1.78Q1 | 4.61 0.23 down from 2017 | 1,051 | 100% | $2,157 | ||
8Blood Cancer JournalOASpringer Nature · United Kingdom | 1.76Q1 | 4.12 0.47 down from 2017 | 372 | 100% | $5,290 | ||
9Blood AdvancesOAElsevier BV · United States | 1.74Q1 | 4.22 1.62 up from 2017 | 315 | 100% | $3,800 | ||
10HematologyAmerican Society of Hematology · United States | 1.65Q1 | 3.63 0.43 up from 2017 | 299 | 99% | — | ||
11Transfusion Medicine ReviewsElsevier BV · United States | 1.62Q1 | 4.53 0.08 up from 2017 | 88 | 9% | $3,970 | ||
12Therapeutic Advances in HematologyOASAGE Publishing · United Kingdom | 1.58Q1 | 3.76 1.41 down from 2017 | 84 | 100% | $2,650 | ||
13American Journal of HematologyWiley · United States | 1.54Q1 | 3.68 0.61 down from 2017 | 986 | 81% | $5,450 | ||
14British Journal of HaematologyWiley · United Kingdom | 1.46Q1 | 3.59 0.33 down from 2017 | 1,471 | 60% | $5,190 | ||
15Journal of Blood MedicineOADove Medical Press · New Zealand | 1.41Q1 | 3.57 0.07 up from 2017 | 82 | 100% | $2,320 | ||
16Current Opinion in HematologyLippincott Williams & Wilkins · United States | 1.37Q1 | 3.71 0.34 up from 2017 | 241 | 35% | — | ||
17Transplantation and Cellular TherapyElsevier BV · Netherlands | 1.36Q1 | 3.33 1.14 down from 2017 | 1,028 | 100% | $3,650 | ||
18Seminars in Thrombosis and HemostasisThieme Medical Publishers (Germany) · United States | 1.35Q1 | 3.61 0.31 down from 2017 | 367 | 44% | — | ||
19Pediatric RheumatologyOABioMed Central · United Kingdom | 1.28Q1 | 3.53 0.84 up from 2017 | 248 | 100% | $3,090 | ||
20Transfusion Medicine and HemotherapyOAKarger Publishers · Switzerland | 1.21Q1 | 2.51 0.09 down from 2017 | 182 | 87% | $1,670 | ||
21PlateletsOAInforma · United Kingdom | 1.18Q2 | 3.16 0.58 up from 2017 | 366 | 39% | $2,970 | ||
22Current Hematologic Malignancy ReportsSpringer Science+Business Media · United States | 1.18Q2 | 2.88 0.18 down from 2017 | 184 | 19% | $3,790 | ||
23Bone Marrow TransplantationSpringer Nature · United Kingdom | 1.12Q2 | 2.81 0.31 down from 2017 | 978 | 30% | $4,990 | ||
24Vox SanguinisWiley · United Kingdom | 1.09Q2 | 2.86 0.31 up from 2017 | 307 | 30% | $4,150 | ||
25Current Research in Translational MedicineElsevier BV · France | 1.04Q2 | 2.62 0.88 up from 2017 | 63 | 19% | $3,700 | ||
26TransfusionWiley · United States | 1.01Q2 | 2.94 0.16 down from 2017 | 1,290 | 29% | $4,100 | ||
27Expert Review of HematologyTaylor & Francis · United Kingdom | 1.00Q2 | 2.67 0.61 up from 2017 | 296 | 19% | — | ||
28Experimental HematologyElsevier BV · United States | 0.99Q2 | 2.77 0.06 up from 2017 | 339 | 100% | $3,250 | ||
29European Journal Of HaematologyWiley · United Kingdom | 0.92Q2 | 2.38 0.10 down from 2017 | 465 | 35% | $4,650 | ||
30Best Practice & Research Clinical HaematologyElsevier BV · United Kingdom | 0.91Q2 | 2.26 0.31 up from 2017 | 125 | 22% | $3,730 | ||
31Leukemia ResearchElsevier BV · United Kingdom | 0.88Q2 | 2.23 0.12 down from 2017 | 564 | 20% | $3,910 | ||
32Journal of Clinical ApheresisWiley · United States | 0.88Q2 | 2.51 0.19 up from 2017 | 203 | 24% | $3,920 | ||
33Annals of HematologyOASpringer Science+Business Media · Germany | 0.85Q2 | 2.13 0.01 down from 2017 | 907 | 21% | $4,590 | ||
34Clinical Lymphoma Myeloma & LeukemiaElsevier BV · United States | 0.82Q2 | 2.04 0.29 down from 2017 | 514 | 14% | $3,890 | ||
35International Journal of HematologySpringer Science+Business Media · Japan | 0.81Q2 | 2.25 0.06 down from 2017 | 610 | 22% | $4,390 | ||
36BMC HematologySpringer Science+Business Media · United Kingdom | 0.80Q2 | 1.92 0.01 up from 2017 | 69 | 100% | $2,170 | ||
37HaemophiliaWiley · United Kingdom | 0.78Q2 | 2.44 0.50 up from 2017 | 711 | 39% | $4,760 | ||
38Transfusion MedicineWiley · United Kingdom | 0.76Q2 | 1.91 0.16 up from 2017 | 265 | 15% | $3,700 | ||
39International Journal of Laboratory HematologyWiley · United Kingdom | 0.75Q2 | 1.84 0.04 up from 2017 | 396 | 22% | $3,880 | ||
40Annals of Laboratory MedicineOASeoul National University · South Korea | 0.74Q3 | 1.91 0.45 up from 2017 | 348 | 100% | — | ||
41Leukemia & lymphoma/Leukemia and lymphomaTaylor & Francis · Switzerland | 0.67Q3 | 1.71 0.04 up from 2017 | 1,379 | 20% | — | ||
42Pediatric Hematology and OncologyTaylor & Francis · United Kingdom | 0.67Q3 | 1.50 0.25 up from 2017 | 142 | 9% | — | ||
43Mediterranean Journal of Hematology and Infectious DiseasesOAPAGEPress (Italy) · Italy | 0.65Q3 | 1.71 0.07 up from 2017 | 188 | 100% | $647 | ||
44Transfusion and Apheresis ScienceElsevier BV · United Kingdom | 0.63Q3 | 1.70 0.21 down from 2017 | 421 | 7% | $3,160 | ||
45Cytometry Part B Clinical CytometryWiley · United States | 0.62Q3 | 2.11 0.06 down from 2017 | 267 | 80% | $3,800 | ||
46Leukemia Research ReportsOAElsevier BV · Netherlands | 0.57Q3 | 1.59 0.49 up from 2017 | 59 | 100% | $1,180 | ||
47HematologyOAManey Publishing · United Kingdom | 0.56Q3 | 1.53 0.27 up from 2017 | 266 | 100% | $2,557 | ||
48Research and Practice in Thrombosis and HaemostasisOAElsevier BV · United States | 0.54Q3 | 1.19no 2017 value | 59 | 100% | $2,250 | — | |
49ImmunohematologyExeley Inc · United States | 0.53Q3 | 1.11 0.31 up from 2017 | 70 | 16% | — | ||
50Blood Coagulation & FibrinolysisLippincott Williams & Wilkins · United Kingdom | 0.52Q3 | 1.36 0.22 up from 2017 | 456 | 17% | — |
Subfields of Medicine, with Hematology highlighted.
- Surgery901
- Pulmonary and Respiratory Medicine349
- Public Health, Environmental and Occupational Health289
- Cardiology and Cardiovascular Medicine280
- Oncology224
- Infectious Diseases210
- Epidemiology193
- Endocrinology, Diabetes and Metabolism162
- Neurology161
- Physiology155
- Radiology, Nuclear Medicine and Imaging146
- Psychiatry and Mental health141
- Orthopedics and Sports Medicine115
- Pediatrics, Perinatology and Child Health101
- Ophthalmology95
- Dermatology89
- Hematology78
- Obstetrics and Gynecology73
- Rheumatology65
- Nephrology59
- Complementary and alternative medicine54
- Pharmacology51
- Reproductive Medicine50
- Emergency Medicine42
- Geriatrics and Gerontology34
- Rehabilitation34
- Otorhinolaryngology33
- Pathology and Forensic Medicine30
- Hepatology24
- Critical Care and Intensive Care Medicine23
- Immunology and Allergy21
- Genetics20
- Anesthesiology and Pain Medicine15
- Urology15
- Gastroenterology7
- Internal Medicine4
- Transplantation3
- Family Practice2
- Health Informatics2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2018. Corpus-wide, 81.5% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
23 additional Hematology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2015–2017, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2018. Publication window: 2015–2017. How these summaries are calculated
- Ranked journals
- 78
- Window papers (baseline)
- 37,717 +9.4% from indicator year 2015
- Median OJR
- 0.74 +4.0% from indicator year 2015
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2015–2017 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 37 | 43 | 47 | 48 | 49 | 48 | 48 | 51 | 52 | 55 | 57 | 59 | 60 | 64 | 69 | 71 | 70 | 74 | 78 | 80 | 79 | 83 | 83 | 84 | 83 | 78 | |
| Window papers (baseline) | 15,676 | 17,554 | 18,321 | 19,931 | 20,773 | 22,160 | 23,086 | 23,968 | 25,638 | 27,756 | 31,370 | 32,535 | 33,270 | 32,125 | 33,484 | 34,476 | 35,772 | 36,578 | 37,717 | 39,004 | 40,629 | 43,037 | 45,948 | 47,337 | 47,502 | 47,302 | |
| Median OJR | 0.53 | 0.57 | 0.589 | 0.593 | 0.641 | 0.646 | 0.677 | 0.650 | 0.640 | 0.663 | 0.62 | 0.73 | 0.707 | 0.713 | 0.7205 | 0.716 | 0.7196 | 0.75 | 0.74 | 0.68294 | 0.711 | 0.682 | 0.68287 | 0.63 | 0.587 | 0.658 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.